HMGN4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.054410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.024960E-01
Normal-vs-Stage2
1.229180E-01
Normal-vs-Stage3
7.573900E-02
Normal-vs-Stage4
9.291000E-01
Stage1-vs-Stage2
8.129400E-01
Stage1-vs-Stage3
2.628800E-01
Stage1-vs-Stage4
6.119600E-02
Stage2-vs-Stage3
1.840590E-01
Stage2-vs-Stage4
9.587900E-02
Stage3-vs-Stage4
3.715700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.145180E-01
Normal-vs-AfricanAmerican
2.402600E-01
Normal-vs-Asian
1.363450E-01
Caucasian-vs-AfricanAmerican
7.609600E-01
Caucasian-vs-Asian
5.916400E-01
AfricanAmerican-vs-Asian
5.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.102560E-01
Normal-vs-Female
1.096210E-01
Male-vs-Female
2.742000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.473040E-01
Normal-vs-Age(41-60Yrs)
1.776840E-01
Normal-vs-Age(61-80Yrs)
8.773600E-02
Normal-vs-Age(81-100Yrs)
1.693830E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.665800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.773600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.092400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.070000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.456200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.956400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.224440E-01
Normal-vs-Daily Drinker
3.955600E-02
Normal-vs-Weekly Drinker
9.656300E-02
Normal-vs-Occasional Drinker
1.367400E-01
Normal-vs-Social Drinker
3.387700E-02
Non Drinker-vs-Daily Drinker
2.527400E-01
Non Drinker-vs-Weekly Drinker
6.520800E-01
Non Drinker-vs-Occasional Drinker
7.938400E-01
Non Drinker-vs-Social Drinker
8.803800E-01
Daily Drinker-vs-Weekly Drinker
6.025800E-01
Daily Drinker-vs-Occasional Drinker
1.888420E-01
Daily Drinker-vs-Social Drinker
3.309200E-01
Weekly Drinker-vs-Occasional Drinker
5.111600E-01
Weekly Drinker-vs-Social Drinker
7.364000E-01
Occasional Drinker-vs-Social Drinker
6.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.432200E-02
Normal-vs-Grade 2
2.903800E-03
Normal-vs-Grade 3
7.004300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.860000E-03
Grade 1-vs-Grade 3
3.180200E-02
Grade 1-vs-Grade 4
6.432200E-02
Grade 2-vs-Grade 3
6.878600E-01
Grade 2-vs-Grade 4
2.903800E-03
Grade 3-vs-Grade 4
7.004300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.595200E-01
Normal-vs-NonDiabetic
4.763800E-02
Diabetic-vs-NonDiabetic
4.955400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.044100E-02
Normal-vs-NoPancreatitis
1.103790E-01
Pancreatitis-vs-NoPancreatitis
8.688800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.954300E-02
Normal-vs-N1
1.430980E-01
N0-vs-N1
5.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.030200E-01
Normal-vs-TP53-NonMutant
1.880990E-01
TP53-Mutant-vs-TP53-NonMutant
2.878400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
